Hard data and deep insights on clinical trials strategy & operations
Live Last read · last published · next check
Chemotherapy-free breast cancer options could be particularly beneficial for elderly patients or those with comorbidities, researchers say. The post Chemo-free regimen touts breast cancer win amid targeted therapy shift appeared first on Clinical Trials Arena .
In August, AstraZeneca discontinued the eVOLVE-Lung02 Phase III trial of volrustomig in combination with chemotherapy in first-line mNSCLC. The post AstraZeneca trips in PD-1 bispecific market after Phase III NSCLC failure appeared first on Clinical Trials Arena .
According to the WHO, HNSCC ranks as the seventh most common cancer and is the sixth leading cause of cancer-related mortality worldwide. The post Study finds metabolic biomarker signature to assist with early HNSCC detection appeared first on Clinical Trials Arena .
Adaptin Bio has opened enrolment for a Phase I clinical trial to assess its BRiTE therapy, APTN-101, in adults with glioblastoma. The post Enrolment opens for Adaptin Bio’s Phase I trial of glioblastoma therapy appeared first on Clinical Trials Arena .
Polyrizon has completed agreements with five sites for its planned trial evaluating Nasarix in patients with seasonal allergic rhinitis. The post Polyrizon finalises five site agreements for Nasarix trial appeared first on Clinical Trials Arena .
The US is approaching an key inflection point in the epidemiology of childhood infectious diseases amid existing drops in vaccination rates. The post The changing landscape of childhood infectious disease in the US appeared first on Clinical Trials Arena .
Analysts tout this early data as “encouraging” as anti-inflammatory mechanisms garner attention in the neurology and metabolic disease. The post AC Immune’s anti-inflammatory drug posts early-stage win appeared first on Clinical Trials Arena .
The MHRA set out ambitious targets to have a 150-day set-up time, from application to recruitment, for clinical trials in the UK. The post Reforms to UK clinical trial sector showing signs of success appeared first on Clinical Trials Arena .
Scancell Holdings has received CTA from the UK MHRA for a Phase III trial evaluating its ImmunoBody, iSCIB1+, in advanced melanoma patients. The post UK MHRA grants approval for Scancell’s Phase III study of iSCIB1+ appeared first on Clinical Trials Arena .
Novo Nordisk has begun a late-stage clinical trial to evaluate whether lower doses of its Wegovy pill can still deliver weight reduction. The post Novo Nordisk commences study for reduced Wegovy pill dosing appeared first on Clinical Trials Arena .
Since the Phase III results debuted, Moderna’s stock has more than doubled in value as analysts tout their positive commercial implications. The post MSD and Moderna eye cancer vaccine market debut on Phase III melanoma score appeared first on Clinical Trials Arena .
Amylyx acquired the PBH drug from Eiger BioPharmaceuticals during bankruptcy proceedings in 2024. The post Amylyx’s $35m-acquired PBH drug meets endpoints in Phase III trial appeared first on Clinical Trials Arena .
Overton could take the helm at the FDA during a tumultuous period for the agency, defined by several resignations, firings and redundancies. The post Trump expected to nominate Heidi Overton as new FDA commissioner appeared first on Clinical Trials Arena .
Abcuro has closed a $66m Series D funding round to support its new clinical trial of ulviprubart for inclusion body myositis (IBM). The post Abcuro secures $66m to support clinical trial of ulviprubart for IBM appeared first on Clinical Trials Arena .
Lynch Regenerative Medicine has completed participant enrolment in a Phase II trial assessing the rhPDGF-BB as an adjunctive therapy for surgical wounds following skin cancer excision. The post Enrolment concludes in Lynch’s Phase II rhPDGF-BB study appeared first on Clinical Trials Arena .
GlobalData highlighted EyePoint’s Duravyu as a notable drug set to enter the wet AMD market by 2034. The post EyePoint’s Duravyu falls short to Eylea in Phase III trial appeared first on Clinical Trials Arena .
United Therapeutics has completed enrolment for its TETON-PPF study, assessing the safety and efficacy of nebulised Tyvaso as a PPF treatment. The post United Therapeutics completes enrolment for TETON-PPF trial appeared first on Clinical Trials Arena .
